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INTRODUCTION 
 
Diabetes mellitus is a metabolic disorder characterized by 
hyperglycemia,  resulting from defects in insulin secretion, insulin 
action or both.  It may be accompanied by the presence of 
progressive microvascular and macrovascular complications. The 
prevalence of type 2 diabetes is increasing all over the world.  It has 
emerged as a major public health problem in India. 
 
The WHO estimated that there were 31.7 million persons with 
diabetes in India in the year 2000 and this number is likely to  rise by 
71.4 million in 2030.3  
The chronic complications of diabetes includes micro vascular 
complication and macrovascular complication.   
The macrovascular complications includes the cardiovascular 
diseases, cerebrovascular diseases, peripheral vascular diseases.  The 
microvascular complications includes diabetic retinopathy and 
diabetic nephropthy and diabetic neuropathy. Among the 
microvascular complication retinopathy is a dreadful sight 
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threatening one. Retinopathy is considered to be a leading cause of 
blindness in diabetic population.  
Blindness is 25 times more common in diabetic patients than 
non diabetic.  Diabetic retinopathy is ranked as the sixth common 
cause of blindness in India.  While the type 2 diabetes mellitus 
patients may have retinopathy at the time of  diagnosis.  After two 
decades nearly 60% of the type 2 DM patients will have retinopathy.  
The scope of preventing, diagnosing and treating the devastating 
effects of retinopathy on vision is at present  a major issue.16 
 
The incidence of the diabetic retinopathy increases as the age 
advances.  The relative risk is greater between the age of 30-60 
years.  The incidence of vision loss increases with increase in age, 
severity of retinopathy, duration of diabetes, presence of proteinuria   
and hyperglycemia.  
Anemia, a common complication is more prevalent in persons 
with diabetes than in person without diabetes.  Anemia can occurs in  
25% of people with diabetes mellitus.  Anemia may develop earlier 
and more severe in patients with diabetes than in patients with renal 
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impairment from other causes.  The World Health Organisation 
WHO guidelines recommends investigation of anaemia where Hb is 
less than 12g /dl in women and less than 13g /dl in men.16 
 
By using this definition nearly 1 among 4, that is 25% patients 
with  diabetes have anemia. The cause of anemia in diabetic patient 
are diabetic nutritional deficiency, medications used for diabetics 
and related conditions and erythropoietin  deficiency due to diabetic 
nephropathy. 
 
Anemia along with diabetes may increase the likehood of 
developing retinopathy, cardiovascular and  cerebro vascular events. 
People who have both anemia and diabetes are more likely to die 
earlier than those who have diabetes but not anemic. 25 
 
Anemia can lead to false low level of  HbA1C which may 
result in under treatment of hyperglycemia which inturn will 
contribute to the progress of micro and macro vascular 
complications. 26 
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Gender was considered as a significant influencing factor for 
the prevalence of anemia in  population.  Many of the studies have 
demonstrated the role of anemia, as an independent risk factor for 
diabetic retinopathy in patients with type 2 diabetes mellitus and the 
studies also have shown the influence of anemia on the severity of 
diabetic retinopathy in men and women. 
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REVIEW OF LITEATURE 
 
 Diabetes mellitus is now been established as one of the leading 
cause of morbidity and mortality throughout the world. Most of the 
ill effects on health can entirely be attributed to the long term 
complications of diabetes.  
Chronic complications of Diabetes: 15 
 The chronic complications of diabetes can be classified into 
microvascular complication and macrovascular complications 
traditionally. 
Microvascular complication 
 Diabetic retinopathy 
 Diabetic nephropathy 
 Diabetic neuropathy 
Macrovascular complication 
 Cardiovascular disease 
 Peripheral vascular disease 
 Cerebro vascular disease 
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Prevalence of chronic complications of Diabetes in an urban 
South Indian Population (Data from Chennai, urban population study 
(CUPS) and Chennai urban Rural Epidemiology study (CURES) by 
Mohan and Colleagues)16 
 Complication    Prevalence  % 
 Diabetic retinopathy    17.6 
 Diabetic nephropathy    2.2 
 Diabetic neuropathy    17.5 
 Coronary artery disease    21.4 
 Peripheral vascular disease   6.3 
Pathogenesis of Microvascular complications :32 
The development of microvascular disease is related to both 
the duration as well as the severity of hyperglycemia.  
Hyperglycemia can lead to microvascular damage by several 
postulated mechanisms as detailed below.  Although the precise 
mechanisms is not clear there are atleast four possible contributing 
mechanisms  
1) accumulation of sorbitol and other polyols within 
endothelial cells.  
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2) Glucose induced protein kinase C up regulation with 
consequent prostaglandin production.   
3) Glucose induced non enzymatic glycosylation of structural 
and functional proteins and  
4) Glucose induced auto oxidative damage.  
Polyol pathway 
 Activation of the aldose reductase pathway results in sorbitiol 
accumulation, decreased glutathione and production of diacyglycerol 
which in turn activates protein kinases and phospholipases. The net 
effect of activation of these biochemical intermediates is 
vasodilatation with resulting increased blood flow and increased 
vascular permeability. 
 The increased formation and accumulation of sorbitol in 
tissues is accompanied by a depletion of free myoinositol, loss of 
Na/K ATPase activity and increased consumption of the enzyme co-
factors NADPH and NAD, leading to changes in cellular redox 
potential. 
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These metabolic derangements have been postulated to result 
in cellular dysfunction and ultimately the morphological lesions that 
are characteristic of diabetic retinopathy as well as nephropathy. 
Increased Non-enzymatic glycosylation and formation of 
Advanced glycosylation End products 
 Glycosylated haemoglobin may decrease the ability of cells to 
release the oxygen. Alteration of structural cellular proteins may 
decrease the flexibility of red cells, making it more difficult to 
squeeze through capillaries, further decreasing their ability to 
provide oxygen to focal areas. The process of advanced glycation 
represents a complex series of reactions which occur when glucose 
and other reducing sugar react with proteins, lipids and nucleic 
acids.  In diabetes, there occurs a sequence of biochemical reactions, 
many of which are still poorly defined, leading to the formation of a 
range of advanced glycation end products. (AGEs). AGEs bind to 
specific receptors in macrophages, endothelial cells and mesangial 
cells.  Interaction of AGEs with their receptors in measangial cells 
leads to increased transforming growth factor (TGF-B) expression 
and extracellular matrix synthesis. 
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Growth factors : 
 Vascular endothelial growth factor (VEGF) and other growth 
factors have been identified in the retina.  VEGF is up regulated in 
diabetic retinopathy and this has been found to correlate with the 
severity of the retinal changes, particularly neo vascularisation. 
Protein Kinase C 
 Part of the adverse effects of hyperglycemia have been 
attributed to activation of protein kinase C (PKC), a family of serine 
threonine kinases that regulate diverse vascular functions, including 
contractility, blood flow, cellular proliferation and vascular 
permeability.  Specific PKC inhibitors are now undergoing clinical 
trials in diabetic retinopathy and nephropathy. 
 
DIABETIC RETINOPATHY 
 Diabetic retinopathy is the most common cause of blindness in 
diabetic population.  Diabetic retinopathy is often asymptomatic in 
its most treatable stages ; hence early detection through regularly 
scheduled ocular examination is critical. 
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 The prevalence of retinopathy at the time of diagnosis is much 
greater in type 2 (6.7 – 30.2%) as compared to type 1 (0-3%), as the 
former is more likely to remain undiagnosed for longer periods of 
time.  Approximately 1 among 4 diabetes are unaware of their 
disease. 
 
 Prevalence of proliferative Diabetic retinopathy is more in 
long standing type 1 diabetes mellitus.  However, in type 2 diabetes 
mellitus patients on insulin, risk is equally high (25%) possibly 
owing to chronic hyperglycemia.  Most of the diabetic retinopathy 
patients seen in the clinics will be suffering from type 2, rather than 
type 1 diabetes simply because type 2 is seen more commonly in the 
population than type 1, though type 1 are more prone to develop 
retinopathy. 
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RISK FACTORS FOR THE DEVELOPMENT OF DIABETIC 
RETINOPATHY32 
Poor control of Diabetes 
Duration of diabetes 
Hypertension 
Nephropathy 
Obesity and hyperlipidemia 
Smoking 
Anemia 
Pregnancy 
 
Classification and Features  
 
 
 
 
 
 
 
DIABETIC 
RETINOPATHY 
Clinically significant 
macular oedema CSME Proliferative DR 
(PDR) 
Non-proliferative 
DR (NPDR) 
Mild Very severe Severe Moderate 
Background DR Pre-proliferative DR 
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 Mild and Moderate non- proliferative DR was previously 
known as Back ground DR.  Severe and very severe Non-
proliferative DR was known as the Pre-proliferative DR. 
1.  Non Proliferative Diabetic Retinopathy (NPDR) 
Mild NPDR 
 At least one microaneurysm – earliest clinically detectable 
lesion 
 Retinal hemorrhages and hard or soft exudates may be present. 
Moderate NPDR 
 Microaneurysms and / or dot and blot hemorrhages in atleast  
one quadrant 
 Soft exudates (Cotton wool spots) 
 Venous beading or intraretinal microvascular abnormalities 
(IRMA) 
Severe NPDR 
When any one of the following 3 features is present 
 Microaneurysms and intraretinal hemorrhages in all 4 
quadrants 
 Venous beading in 2 or more quadrants 
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 Moderate IRMA in at least 1 quadrant 
 Known as the 4-2-1 rule 
Very severe NPDR 
 When any two of the features of the 4-2-1 rule is present 
 
II -  Proliferative Diabetic Retinopathy 
 Proliferation of new vessels, usually from the veins, is the 
characteristic feature 
 New vessels on the optic disc (NVD) 
 New vessels elsewhere on the retina, along the course of the 
retinal vessels (NVE) 
 
III – Clinically significant Macular Edema (CSME) 
 Presents with dimness of vision 
 Retinal edema close to fovea 
 Hard exudates close to fovea 
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Modified Klein Classification of diabetic retinopathy 
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Pathology and Implications of the features of DR 
 Diabetic retinopathy is caused by damage to blood vessels of 
the retina.  Microaneurysm with microvascular leakage and 
occlusion are its hallmarks.  Larger vessels may also be involved. 
 Saccular outpouchings of the weakened, damaged capillary 
walls produces microaneurysms. In the earlier and less severe stages 
of NPDR, these damaged blood vessels become porous and leak 
fluid into the retina.  This breakdown of blood retinal barrier results 
in retinal oedema and hard exudates. Oedema occurring at the 
macula (CSME) causes blurred vision and requires immediate 
treatment as it can lead to serious loss of vision. 
Extensive microaneurysm, hemorrhages in all parts of the 
retina and venous beading occurring in the later stages of NPDR 
(Severe to very severe NPDR) implies imminent neovascularisation 
(growth of new vessels).  Hence early detection of this stage is 
crucial. 
 Various diabetes induced pathologic changes of the capillary 
walls and the blood cells results in microvascular occlusion leading 
to hypoxia of the retina.  The hypoxic retina, probably attempting to 
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reestablish circulation, releases large amounts of vascular 
endothelial growth factor (VEGF), VEGF is a potent stimulator of 
angiogenesis, the growth of new blood vessels from pre-existing 
ones.32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Hence, in the more advanced stage of Proliferative 
retinopathy, growth of new blood vessels occurs with in the eye.  
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These new vessels are fragile and can bleed causing loss of vision 
and scarring.  This stage is liable to develop complications and 
therefore requires treatment. 
SIGNS AND SYMPTOMS OF DIABETIC RETINOPATHY 
SYMPTOMS : 
1. Difficulty in reading 
2. Blurring of  vision 
3. Sudden loss of  vision in one eye 
4. Seeing ring around lights 
5. Dark spots or flashing light 
SIGNS : 
Diabetic retinopathy often doesn’t have any symptoms or 
warning signs early on. At times the persons may suffer from 
macular edema which causes the vision to rapidly detoriate in a short 
period of time.  Other experience problems with blurred vision 
where they see hollow around the centre of the objects. 
The patient typically notice that they have problem with 
reading print even with the eye glass.  Many patients notice their 
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visions weaken at night while others claims they have problem at 
day especially in bright  sun light. 
Complications of diabetic retinopathy 
All are essentially complications of neovascularisation 
1. Vitreous hemorrhage :  Patient presents with sudden loss of 
vision, usually precipitated by straining while lifting a heavy 
weight or at the toilet and often is the presenting feature of 
undetected PDR. 
2. Tractional retinal detachment (TRD) 
3. Rubeosis Iridis :  Refers to growth of new vessels on the surface 
of iris.  New vessels first appear at the pupillary margin and 
then extend radially towards the angle. 
4. Glaucoma : Neovascular glaucoma is a complication of rubeosis 
iridis, new vessels in angle of anterior chamber cause angle 
closure leading to mechanical obstruction to outflow of aqueous 
through channels in angle. This causes raised intra ocular 
pressure and becomes distorted as iris gets pulled over the 
angle.  Eye becomes painful and red along with progressive loss 
of vision. 
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5. Blindness is due to non clearing vitreous hemorrhage, 
neovascular glaucoma, TRD and macular ischemia. 32 
 
All the above complications are preventable if appropriate 
treatment is instituted early enough.  Herein lays the importance of 
routine fundus examination of diabetic patient and appropriate 
referral to ophthalmologists. 
Screening for Diabetic retinopathy 
The methods of screening for diabetic retinopathy includes 
1. Direct ophthalmoscopy 
2. Indirect ophthalmoscopy 
3. Stereoscopic colour film, fundus photography 
4. Mydriatic or non mydriatic digital color photography 
5. Monochromatic photography 
6. Fluorescent angiography of fundus 
Traditionally ophthalmogist have screened for diabetic 
retinopathy by dilating the pupil and performing indirect 
ophthalmoscopy in which entire retina is examined. 
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The Gold standard for the detection of Diabetic 
retinopathy consists of 30 degree, Streoscopic photography of 
seven standard fields on colour film as developed for the 
ETDRS, classification of diabetic retinonapthy. 
Although retinal imaging program are important in 
improving access to care and identifying patients who need 
further evaluation they do not replace comprehensive  eye 
examinations  by an ophthalmologist. 
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Studies and articles related to Diabetes and Anemia 
1. Prevalence and characteristic of Anemia in Diabetes 22 
Practical Diabetes,  International Journal,  Apr :  2008, Article  
:  vol 25. 
Adetunji,  FWACP, A Olujohungbe, MRCP J. Ronand 
 This article states that there are an increasing number of 
patients with diabetes who have been found to be anemic without 
underlying evidence of chronic renal disease. Over 500 diabetic 
patients were studied and concluded that anaemia was common in 
the study population.  Screening routinely for anemia of Annual 
Diabetic follow up clinic may be cheap and effective way of 
identifying  patient at risk of diabetic related complications 
especially microvascular complication. 
2. Anemia in Diabetes :  An emerging complication of micro 
vascular diseases. 23 
Gurret Diabetes Review S. Jan 2005, November 
Merlin Thomas, Richard macsav, George Serums 
 According to this article :  In diabetic patients, anemia is 2-3 
times more  prevalent than non diabetic, may be due to diabetic 
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nephropathy  induced, reduced erythropoietin systemic 
inflammation, autonomic neuropathy and reduced red cell survival. 
Anemia may be a significant factor in determining the outcome of 
Diabetic microvascular complications like retinopathy. 
3.    Recognizing Anemia in people with Diabetes 25 
National Anemia Action Council,  
NAAC Article Published, March 11, 2009. 
 
In this article, they state that anemia is a common concern and 
can occur in up to 25% of people with diabetes. This is because 
having diabetes for a long time can affect kidneys and nerves. 
 Dr. Janet McGill, diabetologist and associate professor of 
medicine at Washington University in St. Louis stated that “Anemia 
is an under recognized and under treated condition among diabetes 
that can seriously affect their health and well being. 
 Studies show that having anemia along with diabetes may 
increase the likelihood of developing diabetic eye disease, 
developing heart disease or having a stroke.  People who have both 
diabetes and anemia are more likely to die earlier than those who 
have diabetes but not anemia.  Fortunately, anemia can be treated 
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and benefits such as increased energy, activity level and improved 
quality of life can be achieved. 
 
4.  Unrecognised Anemia in patients with Diabetes,  A cross 
sectional survey. 26 
Diabetic Journal .org content 26/4116 
Merlin C, Thomas, MBCHB, Richard J, Macisaac, PhD, Con 
Tsalamandris, MBBS, David Power, MD., PhD and George Jerums, 
MD. 
Prediction of proliferative Diabetic retinopathy with 
hemoglobin level. Archives of ophthalmology November 1, 2009 
127 : 1494-1499. 
 According to this article anemia is common in diabetes, 
potentially contributing to the pathogenesis of diabetes 
complications. This study established the prevalence and 
independent predictors of anemia in a cross sectional survey of 820 
patients with diabetes in long term follow up in a single clinic. 
 A full blood count was obtained in addition to routine blood 
and urine test results for all patients over a 2 year period to 
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encompass all patterns of review.  Predictors of the most recent Hb 
concentration and anemia were identified using multiple and logistic 
regression analysis. 
 A total of 190 patients (23%) had recognized anemia (Hb <12 
g/dl for women and <13g/dl for men).  This prevalence is two to 
three times higher than for patients with comparable renal 
impairment and iron stores in the general population. 
 Anemia is a common accompaniment to diabetes, particularly 
in those with albuminuria or reduced renal function.  Additional 
factors present in diabetes may contribute to the development of 
increased risk for anemia in patients with diabetes. 
5.   Erythropoietic stress and anemia in diabetes mellitus 27 
Pub Med, U.S. National Library of Medicine, National 
Institutes of Health. Nat Rev Endocrinol, 2009 Apr. 5 (4) : 204-10. 
 Singh DK, Winoocur P, FarringtonK. Lister Hospital, Coreys 
Mill Lane, stevenage, Hertfordshire, UK, dsingh4@nts.net. 
 Anemia is one of the world’s most common preventable 
conditions, yet it is often overlooked, especially in people with 
diabetes mellitus.  Diabetes related chronic hyperglycemia can lead 
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to a hypoxic environment in the renal intersititium, which results in 
impaired production of erythropoietin by the peritubular fibroblasts 
and subsequent anemia.  Anemia in patients with diabetes mellitus 
might contribute to the pathogenesis and progression of 
cardiovascular disease and aggravate diabetic nephropathy and 
retinopathy. Anemia occurs earlier in patients with diabetic renal 
disease than in nondiabetic individuals with chronic kidney disease. 
 However, an emphasis on regular screening for anemia, 
alongside that for other diabetes related complications, might help to 
delay the progression of vascular complications in these patients. 
6. Anemia and Diabetic Retinopathy in type II diabetes mellitus. 
30 
JAPI 2010, February   
Padmaja kumari Rani, Rajiv Raman, Sudhir R Rachepalli, 
Swakshyar Saumya Pal, Vaitheeswaran kulothungan, Praveena 
Lakshmipathy, Uthra Satagopan, Govindasamy kumaramanickavel, 
Tarun sharma. 
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 This study conducted at Chennai population by Sankara 
Nethralaya group.  The diabetic retinopathy epidemiology and 
molecular genetic study. ( SN-DREAMS) 
They estimated the prevalence of anemia in persons with type 
2 diabetes mellitus and its role as a risk factor for the presence and 
the severity of diabetic retinopathy, in a population based study. 
5999 subjects from the general population aged >40 years 
were enumerated for the study. A total of 1414 persons identified 
with diabetes underwent comprehensive eye examination, and 
stereoscopic digital fundus photography was used for diabetic 
retinopathy grading. All patients underwent hemoglobin estimation 
for detection of anemia. Univariate and multivariate analyses were 
done to determine the independent risk factors for anemia. 
The prevalence of anemia (Hb <12g/dl in women and <13g/dl 
in men) was 12.3%. Between 40 and 49 years of age, prevalence of 
anemia was higher in women than in men (26.4 % vs 10.3%). Men 
with anemia, and not women, had 2 times the risk of developing 
diabetic retinopathy.  
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Studies and articles related to Diabetic retinopathy and anemia 
7.   Diabetic Retinopathy : An Indian perspective. 19 
   Indian Journal of Medicine 125, March 2007, page 297-310.  
M. Ramar& R. Pradeepa 
 The above mentioned study states that Anemia is considered 
as a risk factor, for diabetic retinopathy because of reduced amount 
of oxygen for the retinal tissue. 
 The diabetic retinopathy in patients with low Hb levels have 
five fold increase risk of severe retinopathy compared to those with 
higher hemoglobin level. 
8.  Metabolic control and diabetic retinopathy 20 
Current diabetes revised  2009  page 5, 3, 7 
Monikar  Rodriguer – fontel, John B. Kernison,  D. Vivsil 
Rifaro 
 This article states that ‘ the independence risk factor for 
progression to proliferative diabetic retinopathy are high levels of 
HbA1C, decreased hematocrit, decreased haemoglobin and 
increased serum lipids. 
9. Seeing between the lines 21 
28 
 
American diabetes Association 
Clinical Diabetes 2003 
 IRL B Hirch. M.D.,  
 This study article shows that anemia appears to be an 
independent risk factor for diabetic retinopathy. Further more acute 
reduction in hematocrit may present in exacerbation of retinopathy. 
Retinal  hypoxia is probably the most important mechanism. 
10.   Diabetic Retinopathy8 
Study Report  by D.Davis, MR Fisher, RE Gangnon, F. 
Barton, L.M. Aiello, E.Y. Chew, L. Ferris 3rd and GL. Knatterud 
 In their study, they showed that the risk factors for the 
development of high risk proliferative diabetic retinopathy (PDR) 
and for the development of severe visual loss were increased 
severity of non proliferative retinopathy, decreased visual acuity (or 
increased extent of macular edema), higher glycosylated 
hemoglobin, diabetic neuropathy, low hematocrit. 
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Studies and articles related to Pathogenesis of anemia and 
retinopathy 
11.  Anemia and elevated systemic levels of vascular endothelial 
growth factor (VEGF) 28 
Pub Med, U.S. National Library of Medicine, National 
Institutes of Health.  Dunst J, Becker A, Lautenschager C, markau, 
S, Becker H, Fischer K, Haensgen G,  
Department of Radiation oncology, Martin-Luther University 
Halle-Witenberg, Juergen, dunst @ medizin, unihalle, de 
 According to this article, Tissue hypoxia is a major stimulus 
for the upregulation of vascular endothelial growth factor. Anemia 
might impact on angiogenesis via impairment of tissue oxygenation.  
The plasma VEGF levels were significantly elevated in 
patients with and without cancers (67.0 +/- 47.5 vs 88.9 +/- 68.8 
pg/ml, n.s.).  In a multivariate model, a significant association 
between low hb levels and increased plasma levels of VEGF was 
confirmed.  In 16 patients with renal anemia, changes in plasma 
VEGF levels decreases after increase in Hb level (p=0.01). 
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Conclusion :  Anemic patients have elevated levels of VEGF.  The 
data suggest that anemia might impact on the progression of 
angiogenesis. 
 
12.  Association of the VEGF with proliferative Diabetic 
Retinopathy in Diabetes 29 
David Ray, Manoj Mishra, Shirley Ralph, Ian Read, Robert 
Davies and Paul Brenchley.   
Dr. David Ray, University of Monchester, Endocrine science 
research groups. 
 Diabetic retinopathy and nephropathy cause significant 
morbidity in patients with diabetes. Vascular endothelial growth 
factor (VEGF) is a potent angiogenic and vascular permeability 
factor and is implicated in both of these diabetes complications.  
They reported in their study showing the VEGF -460 and VEGF 
+405 polymorphisms to increase basal VEGF promoter activity by 
71% compared with the wild type sequence. And also showed the   
association of VEGF polymorphisms with proliferative diabetic 
retinopathy and diabetic nephropathy. 
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 The VEGF – 460 genotype was predictive of retinopathy, even 
after controlling for blood pressure, glycemic control, duration of 
diabetes and obesity (p=0.02).  The VCGF - 460C polymorphism is 
a positive independent predictive factor for the development of 
proliferative diabetic retinopathy. 
 
13.   Diabetic Retinopathy :  An update 31 
Indian Journal of Ophthalmology,  Review Article :  year 
2008, Volume 56, Issue : 3, page 179-188. 
 Ramandeep Singh, Kim Ramasamy, Chandran Abraham, 
Vishali Gupta, Amod Gupta,  Department of ophthalmology, 
Postgraduate Institute of Medical Education and Research, 
Chandigarh, India, Apollo First Med Hospital, Chennai, Tamilnadu, 
India. 
 They state that currently there has been a great interest in 
vasoproliferative factors, which induce neovascularization.  It has 
been shown that retinal ischemia stimulates a pathologic 
neovascularization mediated by angiogenic factors, such as vascular 
endothelial growth factor (VEGF), which results in proliferative 
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diabetic retinopathy (PDR), VEGFs are released by retinal pigment 
epithelium, pericytes and endothelial cells of the retina. 
 In ETDRS, low hematocrit levels at baseline were identified as 
independent risk factor for the development of high risk PDR and 
severe visual loss.  It showed an increased risk of retinopathy in 
patients with the hemoglobin level of less than 12 g / dl. Anemia 
induced retinal hypoxia is speculated as cause of development of 
microaneurysms and other retinopathy changes. 
Studies and articles regarding treatment of anemia and 
retinopathy  
14. Spontaneous closure of micro aneurysm in Diabetic 
retinopathy with treatment of coexisting anemia. 18 
British Journal of ophthalmology, 2005,   
R. Signhi, V. Gupta Dr. Gupta, A. Bhanusali. 
In this article, they state that pathogenesis of diabetic 
retinopathy is multifactorial and various potential risk factors 
including HT, proteinuria, Duration of diabetes, chronic renal failure 
and anemia. 
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 While Anemia has been found as an independent risk factor 
for development of high risk proliferative diabetic retinopathy. It  
has not received due attention in the management of diabetic 
retinopathy and they report a case of 34 year old man with diabetes 
with coexisting nutritional anaemia  who showed spontaneous   
closure of the micro aneurysm after correction of the anemia and 
metabolic control. 
 
15. Diabetic retinopathy 24 
Treating systemic condition aggressively can save sight 
Clevel and Clinician , Journal of medicine :  Nov 5, 2005 
    Stephen, H Sinchair, M.D., Cheive Delereci, Richard Macanut 
MD 
 According to this article, Anemia  often accompanies, Diabetic 
kidney  disease and is  thought to exacerbate the ischemic aspect of 
diabetic retinopathy. 
 Studies of iron supplementation or erythropoietin treatment on 
retinopathy are few and they suggested treatment of anemia is 
associated with fewer new showers of retinal infarct, which may 
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result in a slow progression of capillary non perfusion and 
development of proliferative retinopathy. 
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AIM OF THE STUDY 
 
1. To estimate the prevalence of anemia in patients with 
type 2 diabetic mellitus 
2. And its role as a risk factor for the presence and the 
severity of diabetic retinopathy in Govt. Rajaji Hospital 
diabetic patients. 
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MATERIALS AND METHODS 
 
 The study was conducted in both inpatients and out patients 
of Government Rajaji Hospital, Madurai. 
 Most commonly in the outpatients of Diabetes department 
 The study was conducted from October 2009 to September 
2010. 
 A total of 100 patients were taken for this study. 
 Among the 100 patients, 50 were male and remaining were 
females. 
DESIGN OF STUDY: Cross sectional analytic study 
Selection Criteria : 
Inclusion Criteria: 
1) All the patients selected for the study were aged 40 years 
and above 40 years. 
2) All the patients selected for the study had type 2 diabetes  
3) All the patients selected for the study were attending Govt. 
Rajaji hospital  in patient  out patient department. 
Exclusion Criteria : 
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1) Patients having type I diabetes were excluded from the study. 
2) Patient with age below 40 years were excluded from the study.  
Among the selected patients following variables were taken 
into the consideration. 
1. Gender  
2. Age  
3. Haemoglobin  
4. Blood pressure 
5. Duration of the diabetes 
6. Albuminuria 
7. Diabetic retinopathy 
Gender : 
Among the 100 patients 50 were male and remaining were 
female. 
Age :   According to the age, patients were categorized  
1.   40 – 49 years,    
2. 50 – 59 years,    
3. 60 – 69 years, and  
4. Above 69 years. 
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Duration of Diabetes : 
 The duration of diabetes categorized as  
1. < 5 years,    
2. > 5 years 
Blood pressure : 
 Systolic BP    < 140,   > 140 mmHg 
 Diastolic BP   <  90,   >  90  mm Hg 
Albuminuria : 
 Patient has categorized as 
Absent or Normo albuminuria 
Micro albuminuria 
Macro Albuminuria 
Haemoglobin : 
 Categorized as  
Anemia and  
without anaemia 
Retinopathy : 
 Presence or Absence of retinopathy 
39 
 
Definitions : 
Anemia : 
 According to the WHO guidelines, Anemia was defined as 
haemoglobin concentration  < 13 g / dl  in men and  < 12 g / dl in 
women 
Hypertension : 
 Hypertension was defined as systolic BP > 140 mmHg, 
Diastolic BP > 90 mmHg or patient was on anti hypertensives 
medication. 
Albuminuria : 
 Patient was considered as normo albuminuria or absent if 
albumin creatinine ratio was  < 30 mg / g 
Microalbumuneria : 
 If ACR between 30 – 300 mg / g  
Macro albumuniria  
If ACR  was above 300 mg /g 
Diabetic retinopthy : 
Non sight threatening diabetic retinopathy includes 
1. Mild nonproliferative diabetic retinopathy 
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2. Moderate non proliferative diabetic retinopathy 
Sight threatening retinopathy : 
1. Severe nonproliferative diabetic retinopathy 
2. Proliferative diabetic retinopathy 
3. Macular edema 
Procedure done for the present study 
Estimation of haemoglobin 
Haemoglobin estimation was done by using capillary method 
by calory metric haemoglobunometer (Automated analyzer) in Govt. 
Rajaji Hospital. 
Hb Estimation : 
 The above Hb estimation was done for all the patients taken 
for the study.  
According to the above estimation of haemoglobin patient 
were categorized by haemoglobin level as follows. 
< 11g/dl,  
11-12g/dl,  
12-13 g /dl 
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Abuminuria Estimation : 
Albuminuria estimation was done by fully automatised iimuno 
turbidimetric assay method  using the first morning sample of urine 
of the patient.  The creatinine estimation was done by modified 
JAFFE method.  By using this albumin, creatinine ratio was 
estimated.  According to ACR, patient were categorized  
Normo albuminuria or absent : ACR < 30 mg/g ,   
Micro albuminuria :    ACR  30 – 300 mg /g and  
Macro albuminuria :   ACR   :above 300 mg/g. 
Blood pressure : 
Blood pressure of all the patients were recorded at rest, sitting 
posture in right upper limb with sphygmomanometer and 
categorized those with 
SBP  < 140 mmHg, > 140 mmHg,   
DBP < 90 mm Hg,  > 90 mm Hg 
Fundus examination and diabetic retinopathy grading 
All the patients were examined for the diabetic retinopathy 
after dilating the fundus at ophthalmology department by 
ophthalmologist in Government Rajaji hospital and the fundus 
42 
 
changes for the diabetic retinopathy by using modified Kelin 
classification were recorded as absent retinopathy, non proliferative 
retinopathy, proliferative retinopathy, macular edema. Further 
categorized to absent retinopathy and retinopathy present.  Patients 
having retinopathy were further divided into non sight threatening 
retinopathy or sight threatening retinopathy. 
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 RESULTS AND ANALYSIS 
          The study was conducted on 100 patients in the outpatients 
and inpatients attended Diabetology opd and GRH opd, Madurai. 
          The estimation of haemoglobin and presence of and absence 
of albuminuria was done.  The measurement of the blood pressure of 
the patient was done. The results were analysed effect of anemia on 
diabetic retinopathy as well as severity of retinopathy.  And aslo 
comparing anemia with age, gender,  alminuria and blood pressure  
diabetic retinopathy. 
         The females and males analyzed separately on age, 
hypertension, Albuminuria, retinopathy and severity of retinopathy. 
The gender influence of anemia and retinopathy was analyzed. 
Age vs Anemia in females Table -1 
      In our study, we taken 50 females diabetes out of which 40 
patients had anemia. (80%) remaining 20% have no anemia. 
Among the anemic group anemia is present 92.2% in 40-49 years 
age group that is in younger age group and 83.3% in 50-59 years . 
We also observe anemia was comparatively less in older age (60-69 
years and above 69 years.). 
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Table – 1    
AGE VS ANEMIA (n=50) 
 
 
 
 The above tables shows that anemia present in 40-49 age group is  
95% followed by 83.3% in 50-59 years age group.  
  
 
 
 
 
 
 
   
FEMALE 
(Yrs) 
ANAEMIA  
POSITIVE NEGATIVE TOTAL 
No.of cases PERCENT No.of cases PERCENT  
40-49 20 95.2% 1 4.8% 21 
50-59 10 83.3% 2 16.7% 12 
60-69 05 55.6% 4 44.4% 09 
70+ 05 62.5% 3 37.5% 08 
TOTAL 40  10  50 
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Table - 2 
ANAEMIA Vs  RETINOPATHY (n=50) 
 
The above table shows that retinopathy  is present in 35% of the 
cases in anemia group (hb < 12%)  when comparing to non anemia group 
(hb >12 %)  is  0 %. P value is 0.027.   
 
 
 
 
 
       
FEMALE 
(Hb in 
grams%) 
RETINOPATHY  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<12% 26 65.5% 14 35% 40 
>12% 10 100% 00 0.00% 10 
TOTAL 36  14  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 4.861a 1 0.027 
Anemia Vs Retinopathy : 
 In 50 cases of females with diabetic anemia was present in 40 cases 
Anemia was not present in 10 cases.  Among the anemia group the 
retinopathy was present 35% comparing with non anemic group it was 
0%.  The Chi square test showed p value of 0.027. So in female with 
anemia  presence of retinopathy was statistically significant. 
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Table - 3 
ANAEMIA Vs ALBUMINURIA(n=50) 
 
 
 
Table 3 
Among the 50 female diabetics Albuminuria were present in 13 
case of anemia group whereas albuminuria absent in non anemic patient.  
The chi square test showed the p value of 0.036. So in female diabetic 
presense of anemia statistically significant for the albuminuria. 
 The above table shows that albuminuria  is present in 32.5% of the 
cases in anemia group (hb < 12%)  when comparing to non anemia group 
(hb >12 %)  is  0 %. P value is 0.036.   
 
       
FEMALE 
(Hb in 
grams%) 
ALBUMINIURIA  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<12% 27 67.5% 13 32.5% 40 
>12% 10 100% 00 0.00% 10 
TOTAL 37  13  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 4.392a 1 0.036 
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Table - 4 
ANAEMIA Vs HYPERTENSION(n=50) 
 
Table 4 
In female diabetics hypertension was present in 33% in anemia 
patients whereas non anemic group it was only 0%.  The chi square test 
showed the p value of 0.027. So in female presense of anemia is 
statistically significant for the hypertension. 
The above table shows that hypertension  is present in 35% of the 
cases in anemia group (hb < 12%)  when comparing to non anemia group 
(hb >12 %)  is  0 %. P value is 0.027.   
 
 
       
FEMALE 
(Hb in 
grams%) 
HYPERTENSION  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<12% 26 65.0% 14 35.0% 40 
>12% 10 100% 00 0.00% 10 
TOTAL 36  14  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 4.861a 1 0.027 
48 
 
Table – 5  Duration Vs Retinopathy 
 
In female diabetics duration of diabetes more than 5 years group 
the retinopathy was 53.8% was compared to duration of less than 5 years  
was only 0%.  The chi square test showed the p value of 0.000. So in 
female duration more than 5 years is statistically significant for 
retinopaty. 
 
 
 
 
 
 
       
FEMALE 
(Duration 
DM YRS) 
RETINOPATHY  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<5% 24 100% 00 0.00% 24 
>5% 12 46.2% 14 53.8% 26 
TOTAL 36  14  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 17.949a 1 0.000 
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Table – 6 
DURATION VS ALBUMINURIA 
 
The above table shows that albuminuria is present in 46.2% in 
diabetes mellitus duration of more than 5 years as comparing to diabetes 
less than 5 years group is 0%. P value is 0.001. 
 
 
 
 
 
 
       
FEMALE 
(Duration 
DM YRS) 
ALBUMINURIA  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<5% 23 95.8% 01 4.2% 24 
>5% 14 53.8% 12 46.2% 26 
TOTAL 37  13  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 11.435a 1 0.001 
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Table – 7AGE VS ANEMIA (n=50) 
 
The above tables shows that anemia present in more than 70 age 
group is 100% followed by 62.5% in 60-69 years age group. Anemia is 
less in younger age group ie. 6.7%. 
 
Table 7 
In male patient age vs anemia showed anemia was present in older 
age than younger age in contrary to female diabetes.  In young age of 40-
49 years it was only 6.7% and 50-59 years it was 23.1% while in the 
older age 60-69 years.  It was 62.5%  the above 70 it was 100%.    
 
 
 
       MALE 
(Yrs) 
ANAEMIA  
POSITIVE NEGATIVE TOTAL 
No.of cases PERCENT No.of cases PERCENT  
40-49 01 6.70% 14 93.3% 15 
50-59 03 23.1% 10 76.9% 13 
60-69 10 62.5% 06 37.5% 16 
70+ 06 100% 00 0.00% 06 
TOTAL 20  30  50 
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Table – 8   
ANEMIA VS RETINOPATHY  (n=50) 
 
 
Table 8 
In male patient with anemia the percentage of retinopathy was 
100%   as compared to non anemic group it was 0%.    The chi square test 
showed the p value of 0.000. So in male presence of anemia is 
statistically significant for the diabetic retinopathy. 
The above table shows that retinopathy is present in 100% of the 
cases in anemia group (hb < 13%)  when comparing to non anemia group 
(hb >13 %)  is  0 %. P value is 0.000.   
 
       MALE 
(Hb in 
grams%) 
RETINOPATHY  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<13% 00 0.00% 20 100% 20 
>13% 30 100% 00 0.00% 30 
TOTAL 30  20  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 50.000a 1 0.000 
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Table – 9  
ANEMIA VS ALBUMINURIA  (n=50) 
 
 
 
 
 
 
 
 
Table 9 
In 50 male diabetic patient with anemia albuminuria was present in 
60%   as compared to non anemic group it was 0%.    The chi square test 
showed the p value of 0.000. So in male diabetes with anemia is 
statistically significant for the albuminuria. 
The above table shows that albuminuria  is present in 60% of the 
cases in anemia group (hb < 13%)  when comparing to non anemia group 
(hb >13 %)  is  0 %. P value is 0.000.   
 
 
       MALE 
(Hb in 
grams%) 
ALBUMINIURIA  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<13% 8 40 12 60 20 
>13% 30 100 0 0 30 
TOTAL 38  12  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 23.684a 1 0.000 
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Table -10 
ANEMIA VS HYPERTENSION 
 
Table 10 
In males hypertension was present in 55% of patient with anemia 
the non anemic group it was 0%.    The chi square test showed the p value 
of 0.000. So in male presence of anemia is statistically significant for the 
iabetic retinopathy. 
The above table shows that hypertension  is present in 55% of the 
cases in anemia group (hb < 13%)  when comparing to non anemia group 
(hb >13 %)  is  0 %. P value is 0.000.   
 
 
MALE 
(Hb in 
grams%) 
HYPERTENSION  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT 
<13% 09 45.0% 11 55.0% 20 
>13% 30 100% 00 0.00% 30 
TOTAL 39  11  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 21.154a 1 0.000 
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Table – 11 
DURATION VS RETINOPATHY 
 
The above table shows that retinopathy is present in 66.7% in 
diabetes mellitus duration of more than 5 years as comparing to diabetes 
less than 5 years group is 0%. P value is 0.000.   
Table 11 
In males patients with diabetic more than 5 years, retinopahty was 
present in 66.7 % whereas < 5 years it was 0%.    The chi square test 
showed the p value of 0.000. So in male duration of diabetes more than 5 
years  statistically significant for the diabetic retinopathy. 
 
MALE 
(Duration 
DM YRS) 
RETINOPATHY  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<5% 20 100% 00 0.00% 20 
>5% 10 33.3% 20 66.7% 30 
TOTAL 30  20  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 22.222a 1 0.000 
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Table 12. 
DURATION Vs ALBUMINURIA (n=50) 
 
 
The above table shows that albuminuria is present in 40% in 
diabetes mellitus duration of more than 5 years as comparing to diabetes 
less than 5 years group is 0%. P value is 0.001. 
Table 13 
Comparing the gender influence on retinopathy the male with 
anemia retinopathy was 100%.  In female it was 35% in anemia group.     
The chi square test showed the p value of 0.000. So influence and 
retinopathy is statistically significant for the diabetic retinopathy. It is 
anemia which is influence on the retinopathy not gender.  
 
  MALE 
(Duration 
DM YRS) 
ALBUMINURIA  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<5% 20 100% 00 0.00% 20 
>5% 18 60.0% 12 40.0% 30 
TOTAL 38  12  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 10.526a 1 0.001 
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Table 13. 
ANAEMIA Vs RETINOPATHY 
 
GENDER INFLUENCE 
 
 The above table shows that the retinopathy present in 
males with anemia group is 100%  as comparing to female 
anemic group  retinopathy present is only 35%. 
 
 
 
 
GENDER  
ANAEMIA RETINOPATHY 
No.of cases PERCENT No.of   cases PERCENT 
MALE(50) 20 40% 20 100% 
FEMALE(50) 40 80% 14 35.0% 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 98.28a 1 0.000 
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Table 14.ANAEMIA Vs SEVERE RETINOPATHY(n=50) 
 
 
Table 15.ANAEMIA Vs SEVERE RETINOPATHY(n=50) 
 
       
FEMALE 
(Hb in 
grams%) 
SIGHT THREATENING RETINOPATHY  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCENT  
<12% 37 92.5% 03 7.5% 40 
>12% 10 100% 00 0.00% 10 
TOTAL 47  03  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 0.798a 1 0.372 
       MALE 
(Hb in 
grams%) 
SIGHT THREATENING RETINOPATHY  
ABSENT PRESENT TOTAL 
No.of cases PERCENT No.of cases PERCEN
T 
 
<13% 15 75% 05 25% 20 
>13% 30 100% 00 0.00% 30 
TOTAL 45  05  50 
CHI SQUARE TESTS 
 Value df P value 
Pearson chi-square 8.333a 1 0.004 
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Table 14 
In female patient with anemia the severe form of sight 
threatening retinopathy was 7.5 % comparing to non anemia 
group  the percentage is  0%.  p value is 0.372. Statistically not 
significant  So in female the presence of anemia is not a risk 
factor for the severe retinopathy. But the number of patient with 
severe retinopathy was less comparing to non severe group. 
 
Table 15 
 In male patient with anemia the severe form of sight 
threatening retinopathy was present 25 %. Comparing non 
anemic group 0  % with p value  .004.    So in male presence of 
anemia is statistically significant for the severity of retinopathy. 
So in male presence of anemia is a risk factor for the severity of 
retinopathy. 
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DISCUSSION 
In our study we analysed the significance of anemia in type 2 
diabetic patients with retinopathy and compared anemia with other risk 
factors like gender,albuminuria,duration of diabetes and hypertension 
both in males and females separately 
In our study results we observed that the percentage of anemia in 
type 2 diabetes was more than we expected. 
The anemia is more common in diabetic both men and women.In 
our study we also observed that the percentage of anemia in women with 
type2 diabetes is more than men. 
The study also shows that anemia is more in younger women than 
in men.In females aged 40-49 yrs maximum percentage of anemia was 
noted (95.2%)and in men it was at its maximum between 60-69 yrs 
(62.5%)and above 70 yrs(100%). 
After the fifth decade however there was no difference in the 
anemia  noted both in women and men .The possible reasons would be 
the onset of menopausal period around this age in women as the literature 
shows.  
 In our study we observed that the diabetic patient with anemia are 
more likely to develop diabetic retinopathy than without anemia. In men 
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the risk of developing diabetic retinopathy is increased as compared with 
women.  This observation is supported by the study by Quing Quiou et al6  
They reported the odds ratio of 2 for the presence of diabetic retinopathy 
and retinopathy increased with anemia, in a cross sectional study of more 
than 1600 individuals with type 2 diabetes mellitus.  
In our study we observed females with anemia the percentage of 
diabetic retinopathy was 35% compared with females without anemia 
0%. 
We also observed men with anemia, the diabetic retinopathy was 
100% compared with the men without anemia (0%). (100% Vs 0%) with 
significant P value (0.000). 
 In our study we found that sever sight threatening Retinopathy was 
present in 5 cases in men. The statistical analysis of anemia versus sever 
Retinopathy showed. Significant P value (0.002) so in men anemia is a 
Risk factor for the severity of retinopathy. 
 In our study we also found that sever sight threatening retinopathy 
was present in 3 cases in women.  The statistical analysis of anemia 
versus sever Retinopathy showed no Significant P value (0.002) so in 
women anemia is not a Risk factor for the severity of retinopathy. 
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 These observation is supported by the study done by Dr.Gupta 
et.al., they reported anemia was an Independent risk factor for High risk 
sever Prolifirative Retinopathy.  
 This observation is also supported by the study by Davis et al 
ETDRS8 (Early treatment diabetic retinopathy study) evaluated the effect 
of anemia on retinopathy by hematocrit  measurement. They reported that 
in low hemotocrit group (< 40 % in month and < 35% in females) 
retinopathy was noted and reported anemia as an independent risk factor 
for the development of high risk. Diabetic retinopathy and serve vision 
loss over a 5 year follow with odds ratio of 1.52. 
 Similar risk of anemia with sever retinopathy was also recorded in 
case series by Shorb et al 9. 
 Other observation of our study shows, albuminuria is present in 
60% of men with anemia and it is 0% men  without anemia on the other 
hand the observation shows albuminuria is present in 32.5% in women 
with anemia and 0% in Non anemic group. Eventhough the effect of 
anemia an albuminuria is statistically significant P value is observation is 
probably not entirely due to anemia. Presence of anemia  increases the 
likehood of albuminuria.          
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 In our study we found that in men with anemia the hypertension is 
present in 55% comparing to non anemic group 0% is observed. Also true 
for female with anemia with significant P value. Eventhough our study 
showed the significances of anemia on hypertension it is not entirely due 
to anemia because Hypertension is Multi factorial cassation. Presence of 
anemia  increases the likehood of hypertension.          
In our study, we observed the duration of diabetes is definitely 
influencing with retinopathy and albuminuria (66.7% vs 0, 40 Vs 0, 53 vs 
0, 46.2 vs 0) in men and women respectively. 
Finally, detection of anemia and its treatment is important in the 
management of diabetic retinopathy. In those patients who had both 
anemia and diabetic mellitus Friedman and associates14 reported that the 
treatment of anemia with erythropoietin was correlated with substantial 
resolution of macular hard exuadate. The improved haemoglobin 
concentration with therapy of anemia improves the tissue oxygenation 
and may result in reduced VEGF production which improves this 
hyperpermeability and reduces the stimulous for neovascularization. 
There by prevents the new vessel formation in retina and reduce the 
diabetic retinopathy. So these observations suggest that anemia 
evaluation should be considered in routine management of persons with 
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diabetic and could be treated to minimize the risk of micro vascular 
complications like retinopathy. 
Eventhough our study and previously done other studies like SN 
DREAMS, Padmaja kumar et al10 also showed the anemia in type 2 
diabetic patient is a risk factor for the presence of diabetic retinopathy the 
cause and  relationship between anemia and diabetic retinopathy has to be 
proved by longitudinal studies in near future. 
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SUMMARY  
 
1. As every body know, the incidence of type 2 diabetes mellitus is 
increasing world wide especially in India. Among the 
complications of diabetes mellitus, retinopathy is the most 
important, dreadful and devastating complication as loss of vision 
is inevitable without treatment. 
2. Anemia is more common in diabetic population. And anemia in 
diabetic women is more common than men and also more common 
in young women than young men. 
3. The presence of anemia in type 2 diabetes mellitus  patients is a risk 
factor for the development of diabetic retinopathy. 
4. Infact, anemia is an independent risk factor for the presence of 
diabetic retinopathy. 
5. The percentage of retinopathy in men is more than women in 
anemic group. Severity of retinopathy is more in men with anemia. 
6. So, early detection of anemia and treating it  will save the sight of 
Millions and Millions of people with diabetes.  
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CONCLUSION 
 
1. Diabetes mellitus is one of the serious disease affecting the 
largest population world wide. 
2. Diabetic retinopathy is a sight threatening preventable 
complication. 
3. Anemia is more common in Diabetic population both men and 
women. 
4. Anemia is one of the independent risk factor for the presence of 
diabetic retinopathy. 
5. Presence of anemia in men is risk factor for severe form of 
diabetic retinopathy. 
6. Along with life style modification and strict glycemic control, 
early detection of anemia in diabetic patient and treating the 
anemia irrespective of the cause of anemia will prevent the 
micro vascular complications especially diabetic retinopathy. 
7. Every tenth individual in diabetic population could be anemic. 
8. Identifying and treating anemia would make a great impact in 
managing diabetic retinopathy. 
 NORMAL FUNDUS 
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